|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.270 USD | -1.51% |
|
-4.66% | +49.32% |
| Capitalization | 315M 272M 246M 235M 428M 29.03B 440M 2.9B 1.16B 13.88B 1.18B 1.16B 50B | P/E ratio 2025 * |
-1.56x | P/E ratio 2026 * | -1.84x |
|---|---|---|---|---|---|
| Enterprise value | 181M 157M 142M 135M 247M 16.74B 254M 1.67B 667M 8B 681M 667M 28.82B | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
96.9% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Cabaletta Bio, Inc.
| 1 day | -1.51% | ||
| 1 week | -4.66% | ||
| Current month | -1.51% | ||
| 1 month | +27.24% | ||
| 3 months | +38.56% | ||
| 6 months | +80.66% | ||
| Current year | +49.32% |
| 1 week | 3.04 |  | 3.54 |
| 1 month | 2.74 | | 3.78 |
| Current year | 2 | | 3.78 |
| 1 year | 0.99 | | 3.78 |
| 3 years | 0.99 | | 26.35 |
| 5 years | 0.59 | | 26.35 |
| 10 years | 0.59 | | 26.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 01/04/2017 | |
Anup Marda
DFI | Director of Finance/CFO | 48 | 01/01/2019 |
Qing Sarah Yuan
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 64 | 01/04/2017 | |
Mark Simon
BRD | Director/Board Member | 64 | 01/10/2018 |
| Director/Board Member | 70 | 19/02/2019 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -7.56% | 0% | 293,477 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.51% | -4.66% | +82.68% | -53.81% | 315M | |
| -1.03% | -1.53% | +20.96% | +95.67% | 44.8B | |
| -1.34% | +0.95% | +50.72% | +15.79% | 40.35B | |
| -3.09% | -6.99% | +89.15% | +675.31% | 30.05B | |
| +8.28% | -12.49% | -7.67% | -28.72% | 21.8B | |
| -2.60% | -0.85% | +48.90% | -30.00% | 19.09B | |
| -1.84% | -2.06% | +27.10% | -28.71% | 16.72B | |
| -2.26% | +10.10% | +56.84% | +183.23% | 13.53B | |
| -1.53% | +4.55% | -13.08% | +979.19% | 12.47B | |
| -4.38% | +5.35% | +65.70% | - | 12.1B | |
| Average | -1.14% | +1.69% | +42.13% | +200.88% | 21.12B | |
| Weighted average by Cap. | -0.93% | +0.06% | +39.34% | +191.88% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -173M -149M -135M -129M -235M -15.95B -242M -1.6B -636M -7.63B -649M -635M -27.47B | -202M -175M -158M -151M -275M -18.63B -283M -1.86B -743M -8.91B -758M -742M -32.09B |
| Net Debt | -133M -115M -104M -99.46M -181M -12.29B -186M -1.23B -490M -5.88B -500M -490M -21.17B | -102M -88.04M -79.49M -76.02M -139M -9.4B -142M -940M -375M -4.49B -382M -374M -16.18B |
Employees
150
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/03/26 | 3.270 $ | -1.51% | 1,554,842 |
| 10/03/26 | 3.320 $ | +1.53% | 2,026,364 |
| 09/03/26 | 3.270 $ | +3.15% | 1,612,361 |
| 06/03/26 | 3.170 $ | -0.31% | 1,408,623 |
| 05/03/26 | 3.180 $ | -7.29% | 1,617,516 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
3.270USD
Average target price
13.12USD
Spread / Average Target
+301.38%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CABA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition